Literature DB >> 7165511

The immunological response of pigs and guinea pigs to antigens of African swine fever virus.

A J Forman, R C Wardley, P J Wilkinson.   

Abstract

Pigs vaccinated with glutaraldehyde-fixed alveolar macrophages (AM) infected with African swine fever virus (ASFV) had an accelerated serological response after subsequent challenge and a slight reduction in levels of viraemia. Vaccination of pigs with detergent-treated infected AM produced no detectable serological response and no protection against homologous challenge. Guinea pigs were vaccinated with glutaraldehyde-fixed ASFV-infected cells, detergent-treated infected cells, detergent-treated infected spleen homogenate, purified ASFV or sonicated infected cells. Antibody was detectable by ELISA after vaccination with all preparations except the detergent-treated infected spleen vaccine. However, vaccination with purified ASFV or sonicated infected cells induced antibodies that were also strongly reactive in antibody-dependent cell-mediated cytotoxicity and complement-mediated lysis assays. If such antibodies are protective, immunization of pigs with purified ASFV or sonicated infected cells may induce a protective immunity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7165511     DOI: 10.1007/bf01314703

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  Persistence of viremia and immunity in African swine fever.

Authors:  D E DETRAY
Journal:  Am J Vet Res       Date:  1957-10       Impact factor: 1.156

2.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

3.  Enzyme-labelled immunosorbent assay techniques in foot-and-mouth disease virus research.

Authors:  E M Abu Elzein; J R Crowther
Journal:  J Hyg (Lond)       Date:  1978-06

Review 4.  Immunology of African swine fever.

Authors:  C J De Boer; I C Pan; W R Hess
Journal:  J Am Vet Med Assoc       Date:  1972-02-15       Impact factor: 1.936

5.  African swine fever virus. Pathogenesis.

Authors:  L Coggins
Journal:  Prog Med Virol       Date:  1974

6.  DNA-dependent RNA polymerase in African swine fever virus.

Authors:  J Kuznar; M L Salas; E Viñuela
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

7.  Lymphocyte function and cell-mediated immunity in pigs with experimentally induced African swine fever.

Authors:  J M Sanchez-Vizcaino; D O Slauson; F Ruiz-Gonzalvo; F Valero
Journal:  Am J Vet Res       Date:  1981-08       Impact factor: 1.156

8.  The excretion of two virulent strains of African swine fever virus by domestic pigs.

Authors:  A Greig; W Plowright
Journal:  J Hyg (Lond)       Date:  1970-12

9.  Complement-mediated lysis of African swine fever virus-infected cells.

Authors:  S G Norley; R C Wardley
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

10.  Effect of African swine fever on lymphocyte mitogenesis.

Authors:  R C Wardley
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

View more
  16 in total

1.  Simultaneous Deletion of the 9GL and UK Genes from the African Swine Fever Virus Georgia 2007 Isolate Offers Increased Safety and Protection against Homologous Challenge.

Authors:  Vivian O'Donnell; Guillermo R Risatti; Lauren G Holinka; Peter W Krug; Jolene Carlson; Lauro Velazquez-Salinas; Paul A Azzinaro; Douglas P Gladue; Manuel V Borca
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 2.  African Swine Fever virus. Brief review.

Authors:  R C Wardley; C de M Andrade; D N Black; F L de Castro Portugal; L Enjuanes; W R Hess; C Mebus; A Ordas; D Rutili; J Sanchez Vizcaino; J D Vigario; P J Wilkinson; J F Moura Nunes; G Thomson
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  Characterization of African swine fever virus antigenic proteins by immunoprecipitation.

Authors:  G J Letchworth; T C Whyard
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

4.  Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice.

Authors:  Xinxin Chen; Jifei Yang; Yanhong Ji; Edward Okoth; Bin Liu; Xiaoyang Li; Hong Yin; Qiyun Zhu
Journal:  Virol Sin       Date:  2016-03-11       Impact factor: 4.327

5.  Purification and properties of African swine fever virus.

Authors:  A L Carrascosa; M del Val; J F Santarén; E Viñuela
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

6.  Association of the Host Immune Response with Protection Using a Live Attenuated African Swine Fever Virus Model.

Authors:  Jolene Carlson; Vivian O'Donnell; Marialexia Alfano; Lauro Velazquez Salinas; Lauren G Holinka; Peter W Krug; Douglas P Gladue; Stephen Higgs; Manuel V Borca
Journal:  Viruses       Date:  2016-10-22       Impact factor: 5.048

7.  BA71ΔCD2: a New Recombinant Live Attenuated African Swine Fever Virus with Cross-Protective Capabilities.

Authors:  Paula L Monteagudo; Anna Lacasta; Elisabeth López; Laia Bosch; Javier Collado; Sonia Pina-Pedrero; Florencia Correa-Fiz; Francesc Accensi; María Jesús Navas; Enric Vidal; María J Bustos; Javier M Rodríguez; Andreas Gallei; Veljko Nikolin; María L Salas; Fernando Rodríguez
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

8.  Thoughts on African Swine Fever Vaccines.

Authors:  Daniel L Rock
Journal:  Viruses       Date:  2021-05-20       Impact factor: 5.048

9.  DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies.

Authors:  Jordi M Argilaguet; Eva Pérez-Martín; Miquel Nofrarías; Carmina Gallardo; Francesc Accensi; Anna Lacasta; Mercedes Mora; Maria Ballester; Ivan Galindo-Cardiel; Sergio López-Soria; José M Escribano; Pedro A Reche; Fernando Rodríguez
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

10.  Live attenuated African swine fever viruses as ideal tools to dissect the mechanisms involved in viral pathogenesis and immune protection.

Authors:  Anna Lacasta; Paula L Monteagudo; Ángeles Jiménez-Marín; Francesc Accensi; María Ballester; Jordi Argilaguet; Iván Galindo-Cardiel; Joaquim Segalés; María L Salas; Javier Domínguez; Ángela Moreno; Juan J Garrido; Fernando Rodríguez
Journal:  Vet Res       Date:  2015-11-20       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.